ContraFect to Present at Jefferies 2016 Healthcare Conference
June 01, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - June 01, 2016) -
ContraFect Corporation
(NASDAQ: CFRX)
(NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of...
Melinta Therapeutics’ Baxdela™ Successfully Achieves Endpoints in Confirmatory Phase 3 Study in Patients with Hospital-Treated Skin Infections
May 12, 2016 08:00 ET
|
Melinta Therapeutics
New Haven, CT, May 12, 2016 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, today announced top-line results...
ContraFect Announces First Quarter 2016 Results
May 10, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - May 10, 2016) -
ContraFect Corporation
(NASDAQ: CFRX)
(NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein...
ContraFect to Present CF-301 Phase 1 Trial Data at the 26th ECCMID Conference
March 29, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - March 29, 2016) -
ContraFect Corporation
(NASDAQ: CFRX)
(NASDAQ: CFRXW), a biotechnology company focused on the discovery and...
ContraFect Corporation Announces Organizational Changes
March 22, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - March 22, 2016) - ContraFect Corporation (NASDAQ: CFRX)(NASDAQ: CFRXW) (the "Company"), a biotechnology company focused on the discovery and development of protein...
ContraFect Announces Fourth Quarter and Full Year 2015 Results
March 15, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - March 15, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect Corporation to Announce Fourth Quarter and Full Year 2015 Results on March 15, 2016
March 08, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - March 08, 2016) -
ContraFect Corporation
(NASDAQ: CFRX)
(NASDAQ: CFRXW), a clinical-stage biotechnology company focused on the discovery and...
ContraFect to Present at 18th Annual BIO CEO and Investor Conference
February 02, 2016 07:00 ET
|
ContraFect Corporation
YONKERS, NY--(Marketwired - February 02, 2016) -
ContraFect Corporation
(NASDAQ: CFRX)
(NASDAQ: CFRXW), a biotechnology company focused on the discovery and...
Melinta Therapeutics Presents Complete Delafloxacin Results from Phase 3 Study in Patients with Acute Bacterial Skin and Skin Structure Infections at ID Week
October 09, 2015 15:30 ET
|
Melinta Therapeutics
NEW HAVEN, CT and SAN DIEGO, Oct. 9, 2015 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, today announced...
Melinta Therapeutics Study Demonstrates Significant Burden of Obesity on Patients' Recovery from Acute Bacterial Skin Infections
May 19, 2015 16:00 ET
|
Melinta Therapeutics
New Haven, CT, May 19, 2015 (GLOBE NEWSWIRE) -- Melinta Therapeutics today presented data that show the negative
impact of obesity on patients' recovery from acute bacterial skin
and skin structure...